SERTRALINE HCL |
C.A.S No. |
79559-97-0 |
Molecular Formula |
C17H17Cl2N.HCl |
Chemical Name |
(1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine Hydrochloride |
|
|
|
|
|
|
Test |
|
Specification |
|
Description |
: |
Off-White to white crystalline powder. |
|
Solubility |
: |
Sparingly Soluble in Methanol. Slightly soluble in Dimethyl formamide |
|
Identification By HPLC |
: |
The IR spectrum of sample d should be concordant with the spectrum of reference standard |
|
Melting Range |
: |
Between 240 - 250°C |
|
Loss On Drying |
: |
Not More Than 0.50 % w/w |
|
Sulphated Ash |
: |
Not More Than 0.10 % w/w |
|
Heavy Metals |
: |
Not More Than 10 ppm |
|
Sp. Optical Rotation (C=0. 05N Methanolic Acid) |
: |
+ 38 to + 42° |
|
Related substances by HPLC
|
|
|
|
» |
Single Impurity |
: |
NMT 0.20% |
|
» |
Total Impurities |
: |
NMT 0.50% |
|
Assay (on anhydrous basis) |
: |
Not Less than 98.0% and Not More Than 102.0% |
|
Residual solvents |
: |
Methanol Not More Than 2000 ppm |
|
|
|
Ethylacetate Not More Than 3000 ppm |
|
|
|
USES |
Sertraline is used to treat depression, panic attacks, obsessive compulsive disorders (OCD), and post-traumatic stress disorder (PTSD). This medication works by helping to restore the balance of certain natural chemicals in the brain. This medication has also been used to treat a severe form of premenstrual syndrome (premenstrual dysphoric disorder- PMDD) and a sexual function problem in men (premature ejaculation |
|
|
|